Sriharsha Tella to United States
This is a "connection" page, showing publications Sriharsha Tella has written about United States.
Connection Strength
0.270
-
Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database. J Clin Endocrinol Metab. 2018 09 01; 103(9):3566-3573.
Score: 0.064
-
Incidence, racial disparities and survival outcomes of mast cell malignancies: analysis from a national database. Leuk Lymphoma. 2018 09; 59(9):2254-2257.
Score: 0.061
-
Incidence, Clinical Features, and Outcomes of Langerhans Cell Sarcoma in the United States. Clin Lymphoma Myeloma Leuk. 2019 07; 19(7):441-446.
Score: 0.017
-
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. Oncologist. 2019 04; 24(4):537-548.
Score: 0.017
-
Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2019 03 01; 17(3):229-236.
Score: 0.017
-
Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma. HPB (Oxford). 2019 03; 21(3):379-386.
Score: 0.016
-
Fluoroquinolone-associated suicide. Eur J Intern Med. 2018 09; 55:e21-e22.
Score: 0.016
-
A population-based analysis of second primary malignancies in T-cell neoplasms. Br J Haematol. 2019 04; 185(2):338-342.
Score: 0.016
-
T cell/histiocyte-rich large B cell lymphoma: incidence, demographic disparities, and long-term outcomes. Br J Haematol. 2019 04; 185(1):140-142.
Score: 0.016
-
Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States. Clin Lymphoma Myeloma Leuk. 2018 07; 18(7):475-479.
Score: 0.016
-
Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood. 2018 01 11; 131(2):265-268.
Score: 0.015